Azafaros
Developer of therapeutics for rare lysosomal storage disorders.
2
Funding Rounds
$174.5m
Money raised
Overview
Developer of therapeutics for rare lysosomal storage disorders.
- Website:
- Headquarters: Naarden
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Azafaros has raised a total of $174.5m in funding over 2 rounds.
Key Insights:
- Azafaros Series B Round, May 2025: $147m
- Azafaros , February 2020: $27.5m
Azafaros Series B Round, May 2025
$147m
Azafaros , February 2020
$27.5m
Industries
Azafaros is active in the following industries: